FDA to Require Agency-Wide Training in Use of Patient-Reported Outcomes

Clinical Trials Advisor
A new requirement has been added to the FDA’s Reviewer Certification Program — training in the development, evaluation and use of patient-reported health outcomes, the agency said in its first report on PROs in medical device premarket submissions and post-market studies.

To View This Article:


Subscribe To Clinical Trials Advisor